Caravel Bio is a biotechnology company developing an integrated platform for protein discovery and engineering.
Caravel Bio has raised $1.2M in total funding. The most recent round was Grant. The last funding was announced in October 2026.
Caravel Bio's investors include Pioneer Fund, National Science Foundation, 2048 Ventures, Portland Seed Fund, The Venture Collective.
Caravel Bio is headquartered in Portland, United States.
Caravel Bio is a biotechnology company developing an integrated platform for protein discovery and engineering.
Caravel Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Caravel Bio — Funding & Investors." VCBacked, October 28, 2026, https://www.vcbacked.co/company/caravel-bio. Accessed November 14, 2026.
VCBacked. (2026). Caravel Bio — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/caravel-bio
{{cite web |title=Caravel Bio — Funding & Investors |url=https://www.vcbacked.co/company/caravel-bio |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Caravel Bio? Request a listing update